000 01611 a2200493 4500
005 20250515182555.0
264 0 _c20091009
008 200910s 0 0 eng d
022 _a1365-2249
024 7 _a10.1111/j.1365-2249.2009.03975.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMessias-Reason, I J
245 0 0 _aFicolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease.
_h[electronic resource]
260 _bClinical and experimental immunology
_cSep 2009
300 _a395-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCase-Control Studies
650 0 4 _aChild
650 0 4 _aChronic Disease
650 0 4 _aFemale
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aHaplotypes
650 0 4 _aHumans
650 0 4 _aLectins
_xblood
650 0 4 _aLogistic Models
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPolymorphism, Single Nucleotide
650 0 4 _aPromoter Regions, Genetic
650 0 4 _aRheumatic Fever
_xgenetics
650 0 4 _aRheumatic Heart Disease
_xgenetics
650 0 4 _aRisk
650 0 4 _aStreptococcal Infections
_xgenetics
650 0 4 _aYoung Adult
650 0 4 _aFicolins
700 1 _aSchafranski, M D
700 1 _aKremsner, P G
700 1 _aKun, J F J
773 0 _tClinical and experimental immunology
_gvol. 157
_gno. 3
_gp. 395-9
856 4 0 _uhttps://doi.org/10.1111/j.1365-2249.2009.03975.x
_zAvailable from publisher's website
999 _c19070605
_d19070605